Kangsheng global medical special examination group (hereinafter referred to as "Kangsheng global") is the first and largest high-end medical special examination service inspection group in China. Kangsheng global is committed to leading the progress of special examination technology and services in China, so as to promote the development and improvement of specialized diagnosis and treatment and personalized medicine in China. In line with the tenet of putting patients' interests first and doctors' needs first, Kangsheng universal follows international norms, standards and industry guidelines, introduces and develops the most advanced technology and special examination methods in the world, and provides comprehensive, advanced and accurate special examination services for large-scale tertiary hospitals, specialized hospitals and general hospitals in China. The core members of the group's entrepreneurship and management team have worked in the academic and industrial circles of the United States for more than ten years, with broad vision and rich experience. The group has received capital support of tens of millions of US dollars from KPCB, Chenxing venture capital, China economic cooperation and paya, the world's most famous and largest venture capital fund. And on June 27, 2011, Mayoclinic of the United States announced that it has signed a strategic cooperation agreement with China global medical special inspection group for several years. Mayo has invested in global health. Through its Department of medical testing and pathology and its Mayo Medical Laboratory, it has provided global health with nearly 3000 professional testing technologies and laboratory quality management, international certification standards and information Consulting, SOPs, methodology and other related technologies will help Corson global to accelerate the development of its high-quality special examination services in China and promote the improvement of medical diagnosis and treatment level in China. Kangsheng global has established and is in the process of building 38000 square meters of clinical testing, scientific research cooperation and application development center with international advanced level and national qualification in Beijing, Shanghai and Wuhan. It has high-resolution flow cytometry, multi-color flow cell sorting and cell culture, multi-color fluorescence real-time young cell scanning imager, second-generation genomics sequencing, gene chip, and full-scale fluorescence Automatic DNA / RNA extraction, Cobas high-sensitivity viral load system, high-precision mass spectrometry, mass spectrometry chip, high-pressure liquid / gas chromatography, molecular cell, genetic and full-automatic nuclear scanning, denaturing high-performance chromatography, molecular pathology, digital pathology, liquid chip, single molecule digital immune, immunohistochemistry, protein fingerprint, laser confocal microscope, electron microscope, etc Ten technical platforms and professional laboratories provide more than 3000 hospitals in 31 provinces, municipalities directly under the central government and more than 600 cities in China, especially more than 1000 large tertiary hospitals, with more than 3000 high-end diagnostic tests in the fields of blood, tumor, genetics, cardio cerebrovascular, infectious diseases, autoimmune diseases, and in the fields of internal, external, women, children and other specialties, and have passed the world's top doctors Medical science and technology institutions and large pharmaceutical companies cooperate to provide medical research, drug testing and translational medical research services to clinicians across the country.
本文链接： https://brand.waitui.com/b8bc6d5cc.html 联系电话：18500087003